Crohn Disease

• CLINICAL_TRIALS trial_result · 2007-02-21
  Clinical Trial Update: An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease [Phase 3]

  Phase 3 trial update evaluating omega-3 free fatty acids (Epanova) for maintenance of symptomatic remission in Crohn's disease; the study st…

• FDA approval · 2006-12-08
  FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)

  FDA approved a supplemental application for infliximab submitted by Janssen Biotech, Inc.

• CLINICAL_TRIALS trial_result · 2006-10-11
  Clinical Trial Update: Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease [Phase 1]

  Phase 1 study assessing the safety and biological effects of C326, an IL-6 inhibitor, in Crohn's disease.

• FDA approval · 2006-09-26
  FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)

  The FDA approved a supplemental application for infliximab from Janssen Biotech, Inc., updating the drug's labeling.

• CLINICAL_TRIALS trial_result · 2006-09-11
  Clinical Trial Update: Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution. [Phase 3]

  This clinical trial update describes a Phase 3 study comparing MR enteroclysis with MRI using oral mannitol contrast for imaging the small i…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2006-09-11
  Clinical Trial Update: The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels [Phase 4]

  This Phase 4 study examines how 5-aminosalicylates affect thiopurine metabolite levels in patients with Crohn's disease and ulcerative colit…

• CLINICAL_TRIALS trial_result · 2006-09-11
  Clinical Trial Update: Treatment With Lactobacillus Rhamnosus and Lactobacillus Acidophilus for Patients With Active Colonic Crohn's Disease. [NA]

  A completed clinical trial assessed the use of Lactobacillus rhamnosus and Lactobacillus acidophilus in patients with active colonic Crohn's…

• CLINICAL_TRIALS trial_result · 2006-08-15
  Clinical Trial Update: A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease [Phase 2]

  Phase 2 study evaluating adalimumab for induction of clinical remission in Crohn's disease. The trial status is completed.

• CLINICAL_TRIALS trial_result · 2006-08-15
  Clinical Trial Update: Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease [Phase 3]

  Phase 3 trial evaluating adalimumab for induction of remission in Crohn's disease has completed enrollment/status completed.

• FDA approval · 2006-07-28
  FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)

  FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited, likely to authorize a new contract manufactur…

• FDA approval · 2006-06-05
  FDA Approved: TYSABRI — Supplemental Application (Biogen Inc.)

  The FDA approved Biogen's supplemental application for TYSABRI (natalizumab), resulting in an approved change to the product's labeling/auth…